Washington: President Donald Trump has warned India that the US may retaliate if it did not export anti-malarial drug hydroxychloroquine despite his personal request, saying he would be surprised if New Delhi did not relent as it has good relations with Washington.

Hydroxychloroquine, an old and inexpensive drug used to treat malaria, is seen as a viable therapeutic solution by President Trump to coronavirus that has so far killed more than 10,000 Americans and infected over 3.6 lakh within weeks.

Last week Trump said he has sought help from Prime Minister Narendra Modi to allow the sale of hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.

"I would be surprised if that (not exporting the drug) were his (Prime Minister Modi's) decision. He'd have to tell me that. I spoke to him Sunday morning, called him, and I said we'd appreciate your allowing our supply to come out.

"If he doesn't allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn't there be?" Trump told reporters during a press briefing at the White House on Monday.

His remarks came at a time when both countries are in the grip of the COVID-19 pandemic. "I would be surprised if he would, you know, because India does very well with the United States," Trump said.

Last month, India imposed a ban on the export on hydroxychloroquine, on which Trump is now banking heavily for the treatment of COVID-19 patients.

India has received similar requests from several other countries including its immediate neighbours Sri Lanka and Nepal. India has said that it is reviewing its export ban order.

Notably, India's decision to ban the exports of hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough in its kitty.

Reiterating that for many years, India has been taking advantage of the US on trade, Trump said that he would be surprised if New Delhi was to stop export of hydroxychloroquine to the US.

The Indian Council of Medical Research (ICMR) has recommended the anti-malarial drug for those involved in the care of suspected or confirmed cases of the coronavirus and also, for the asymptomatic household contacts of laboratory confirmed cases.

On Monday, a senior State Department official said that India has been a significant partner of the US in the pharmaceutical sector and it expects similar cooperation to continue between the economies.

India has long been a significant partner of the United States in the pharmaceutical sector, Alice G Wells, the Acting Assistant Secretary of State for South and Central Asia, told reporters during a press briefing.

The Trump administration has already created a national strategic stockpile of 29 million doses of the malaria drug, anticipating that its test results on more than 1,500 COVID-19 patients in New York is yielding positive results.

Global scientists, racing against time to find either a vaccine or a therapeutic cure to the virus, have begun testing hydroxychloroquine and chloroquine as candidates for potential COVID-19 treatments and the FDA last week issued an Emergency Use Authorization for the prescription of the drugs in certain circumstances.

In addition to New York, COVID-19 patients in several States are being treated with hydroxychloroquine, including Michigan and Texas.

Based on some initial results, the Trump administration is banking heavily on using hydroxychloroquine for the successful treatment of coronavirus.

According to Trump, the drug is yielding positive results. If successful, he told reporters that it would be a gift from heaven.

In the next several weeks, health experts in the US have projected between 100,000 to 200,000 deaths due to the coronavirus, which due to human-to-human transmission is spreading like a wildfire in the country.

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



Report: Thufail Muhammad Abudhabi

Dubai: The funeral of four young brothers who died in a tragic road accident near Abu Dhabi drew hundreds of mourners to the Al Qusais cemetery on Tuesday evening, leaving the UAE’s expatriate community in deep shock and grief.

The children Ashaj (14), Ammar (12), Azaam (8) and Ayyash (5) were the sons of Abdul Latheef and Ruksana, natives of Kerala’s Malappuram district. The family was returning to their Dubai residence after attending the Liwa Festival on the outskirts of Abu Dhabi when their car met with a fatal accident early Sunday morning.

Three of the children died on the spot, while Azaam succumbed to his injuries on Monday evening during treatment. The family’s domestic helper, Bushra Fayaz (49), also lost her life in the crash. Her body was repatriated to India on Monday night, and funeral rites were held in Kerala on Tuesday.

Abdul Latheef, who sustained injuries in the accident, arrived at the cemetery from Abu Dhabi in a wheelchair, his hand in a sling, to attend the burial of his sons. Mourners described the scene as one of the most heartbreaking they had ever witnessed.

“I have never seen the mass burial of children from the same family. It was devastating for everyone present,” said a social worker who assisted the family.

The couple’s only daughter, Izza (10), survived the accident with minor injuries and is undergoing treatment. Unaware of the loss of her brothers, she was seen playing on a mobile phone from her hospital bed.

Relatives said informing the parents about the tragedy was handled with extreme care. Abdul Latheef was told late on Sunday night, while Ruksana who had undergone surgery for an injury to her hand was informed only on Tuesday after counsellors were brought in to break the news professionally.

Before the burial, the parents were allowed to see their children one last time. Ruksana was taken by ambulance to the mortuary, while Abdul Latheef obtained special permission for temporary discharge from hospital to attend the funeral. Ruksana remained hospitalised with her daughter.
Though the family holds Ras Al Khaimah visas, special permission was obtained to conduct the burial in Dubai, where the family resides and where most relatives are based. Community members expressed gratitude to the Dubai authorities for facilitating the process.

Abdul Latheef runs a business in Ras Al Khaimah, while Ruksana works as a property consultant in Dubai. All five children were students of Arab Unity School in Dubai, following the British curriculum. The school management issued a circular to parents outlining measures to support students and families affected by the tragedy and advising on how to discuss the loss sensitively with children.

The cause of the accident has not yet been officially confirmed by Abu Dhabi Police. Public discussions have pointed to possible factors such as dense winter fog and overspeeding, though authorities are yet to release findings.